Andreas Halvorsen Viking Global Investors
Andreas Halvorsen is the founder of Viking Global Investors, another prominent firm with roots in Julian Robertson’s Tiger Management. Viking is known for fundamental long/short equity investing and a large, research-intensive platform. Its public filings are widely monitored for institutional-quality growth and cyclical equity ideas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$568M |
| 2 |
Elevance Health
ELV
|
+$417M |
| 3 |
Salesforce
CRM
|
+$407M |
| 4 |
Meta Platforms (Facebook)
META
|
+$403M |
| 5 |
McKesson
MCK
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$821M |
| 2 |
Centene
CNC
|
+$702M |
| 3 |
American International
AIG
|
+$517M |
| 4 |
Fortive
FTV
|
+$355M |
| 5 |
Parker-Hannifin
PH
|
+$351M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.23% |
| 2 | Financials | 21.32% |
| 3 | Technology | 16.51% |
| 4 | Industrials | 7.74% |
| 5 | Consumer Discretionary | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTLT
51
DELISTED
CATALENT, INC.
CTLT
| $121M | 0.56% |
1,673,755
-287,494
| -15% | -$28.6M |
|
52
Inspire Medical Systems
INSP
$1.8B
| $112M | 0.52% |
633,572
+38,379
| +6% | +$7.71M |
|
53
Intellia Therapeutics
NTLA
$1.8B
| $106M | 0.49% |
1,889,067
-339,316
| -15% | -$21M |
|
|
GTM
54
ZoomInfo Technologies
GTM
$1.16B
| $105M | 0.48% |
+2,512,177
| New | +$107M |
|
55
RH
RH
$2.9B
| $102M | 0.47% |
414,729
+13,499
| +3% | +$3.64M |
|
56
Alibaba
BABA
$286B
| $99.7M | 0.46% |
+1,246,400
| New | +$119M |
|
57
Cadence Design Systems
CDNS
$87.9B
| $99M | 0.46% |
+605,539
| New | +$104M |
|
|
INBX
58
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $95.2M | 0.44% |
5,305,866
| – | – |
|
59
Zai Lab
ZLAB
$2.92B
| $89.4M | 0.41% |
2,614,817
-684,781
| -21% | -$29.3M |
|
60
Progressive
PGR
$127B
| $85.6M | 0.4% |
736,561
-165,183
| -18% | -$19.9M |
|
61
Linde
LIN
$225B
| $84M | 0.39% |
+311,600
| New | +$89.5M |
|
62
Clorox
CLX
$12.9B
| $77.9M | 0.36% |
+606,655
| New | +$87.5M |
|
63
KE Holdings
BEKE
$19.6B
| $68.2M | 0.32% |
3,895,000
-6,515,507
| -63% | -$105M |
|
|
APLS
64
DELISTED
Apellis Pharmaceuticals
APLS
| $63.7M | 0.29% |
+932,441
| New | +$55.2M |
|
65
Rallybio
RLYB
$89.4M
| $60.7M | 0.28% |
524,347
| – | – |
|
66
Avantor
AVTR
$9.78B
| $56.8M | 0.26% |
2,898,662
-3,270,023
| -53% | -$87.6M |
|
67
Rivian
RIVN
$24.6B
| $52.7M | 0.24% |
1,602,193
| – | – |
|
68
CrowdStrike
CRWD
$195B
| $46.9M | 0.22% |
+1,137,316
| New | +$52M |
|
|
SWAV
69
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $43.7M | 0.2% |
157,327
-126,673
| -45% | -$32.2M |
|
70
Edgewise Therapeutics
EWTX
$4.8B
| $43.4M | 0.2% |
4,409,146
+1,681,897
| +62% | +$17M |
|
71
Global E Online
GLBE
$6.81B
| $42.2M | 0.19% |
1,575,580
-1,469,146
| -48% | -$41.8M |
|
|
OHPAU
72
DELISTED
Orion Acquisition Corp. Unit
OHPAU
| $35.8M | 0.17% |
3,629,247
-74,446
| -2% | -$732K |
|
73
4D Molecular Therapeutics
FDMT
$875M
| $31.7M | 0.15% |
3,937,914
| – | – |
|
|
DAWN
74
DELISTED
Day One Biopharmaceuticals
DAWN
| $31.2M | 0.14% |
1,558,563
-298,861
| -16% | -$6.36M |
|
75
CBRE Group
CBRE
$44B
| $27.7M | 0.13% |
+409,714
| New | +$32.5M |
|
Similar funds
Andreas Halvorsen's Q3 2022 Portfolio in Review
As of Q3 2022, Andreas Halvorsen held 102 positions worth $21.7B, down 0.93% from $21.9B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Andreas Halvorsen's Q3 2022 filing shows 20 new, 28 increased, 27 reduced and 14 closed positions. Its largest new stake was Salesforce: 2,400,649 shares worth $345M. The largest sale was T-Mobile US, an estimated $821M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 33% a quarter earlier, followed by Financials and Technology.
- Andreas Halvorsen's largest Q3 2022 buy was Salesforce: 2,400,649 shares worth $345M.
- Andreas Halvorsen added most to Visa in Q3 2022, an estimated $568M increase.
- Andreas Halvorsen's biggest Q3 2022 reduction was T-Mobile US, cutting an estimated $821M.
- Andreas Halvorsen fully exited Centene in Q3 2022, selling an estimated $702M.
- Andreas Halvorsen's ten largest holdings make up 38% of its $21.7B portfolio in Q3 2022.
- Andreas Halvorsen opened 20 new positions and closed 14 in Q3 2022.
- Andreas Halvorsen's portfolio value fell 0.93% quarter-over-quarter to $21.7B.
Based on Viking Global Investors's 13F filing for Q3 2022, filed 14 Nov 2022.